Literature DB >> 21423476

Cardiac sarcoidosis with a rare initial manifestation: sustained monomorphic ventricular tachycardia.

Gautamy Chitiki Dhadham1, Nishant Gupta, Rupen Parikh, Mahesh Bikkina.   

Abstract

Sarcoidosis is a multisystem disease of unknown cause. Life-threatening complications or sudden death can occur when the disease involves the heart. Because cardiac sarcoidosis has diverse clinical presentations, its diagnosis can be a major challenge for clinicians. It is very rare for the initial manifestation of cardiac sarcoidosis to be sustained ventricular tachycardia, especially in a patient with no prior symptoms or history of the disease. Herein, we discuss the case of a 41-year-old black man who presented with nausea, vomiting, and palpitations on the day after he had consumed alcoholic beverages heavily. Electrocardiographic examination revealed sustained monomorphic ventricular tachycardia. An automatic implantable cardioverter-defibrillator corrected the patient's abnormal heart rhythm, and therapy with steroids and β-blockers resolved his symptoms. We describe the process that led to the diagnosis of cardiac sarcoidosis in this patient.

Entities:  

Keywords:  Cardiomyopathies/diagnosis/physiopathology; defibrillators, implantable; diagnosis, differential; echocardiography; magnetic resonance imaging/methods; sarcoidosis/diagnosis/drug therapy/physiopathology/radiography; tachycardia, ventricular/etiology/physiopathology/therapy; treatment outcome

Mesh:

Substances:

Year:  2011        PMID: 21423476      PMCID: PMC3060742     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  16 in total

1.  Cardiac sarcoidosis: spectrum of MRI features.

Authors:  Olivier Vignaux
Journal:  AJR Am J Roentgenol       Date:  2005-01       Impact factor: 3.959

2.  Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging.

Authors:  T Shimada; K Shimada; T Sakane; K Ochiai; H Tsukihashi; M Fukui; S Inoue; H Katoh; Y Murakami; Y Ishibashi; R Maruyama
Journal:  Am J Med       Date:  2001-05       Impact factor: 4.965

3.  The utility of delayed-enhancement magnetic resonance imaging for identifying nonischemic myocardial fibrosis in asymptomatic patients with biopsy-proven systemic sarcoidosis.

Authors:  B Y C Cheong; R Muthupillai; M Nemeth; B Lambert; D Dees; S Huber; R Castriotta; S D Flamm
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2009-07       Impact factor: 0.670

4.  Ventricular tachyarrhythmia associated with cardiac sarcoidosis: its mechanisms and outcome.

Authors:  Hiroshi Furushima; Masaomi Chinushi; Hirotaka Sugiura; Hidehiro Kasai; Takashi Washizuka; Yoshifusa Aizawa
Journal:  Clin Cardiol       Date:  2004-04       Impact factor: 2.882

Review 5.  Sarcoid heart disease: clinical course and treatment.

Authors:  Raed Bargout; Russell F Kelly
Journal:  Int J Cardiol       Date:  2004-11       Impact factor: 4.164

6.  Doppler echocardiographic evaluation of left ventricular diastolic function in patients with systemic sarcoidosis.

Authors:  N Angomachalelis; A Hourzamanis; C Vamvalis; A Gavrielides
Journal:  Postgrad Med J       Date:  1992       Impact factor: 2.401

7.  Detection of myocardial sarcoidosis by thallium 201 imaging.

Authors:  L J Haywood; O P Sharma; M E Siegel; R J Siegel; S L Gottlieb; J Caldwell; J K Siemsen
Journal:  J Natl Med Assoc       Date:  1982-10       Impact factor: 1.798

8.  Doppler echocardiographic detection of left ventricular diastolic dysfunction in patients with pulmonary sarcoidosis.

Authors:  G J Fahy; T Marwick; C J McCreery; P J Quigley; B J Maurer
Journal:  Chest       Date:  1996-01       Impact factor: 9.410

9.  Sustained ventricular tachycardia associated with sarcoidosis: assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia device.

Authors:  S L Winters; M Cohen; S Greenberg; B Stein; J Curwin; E Pe; J A Gomes
Journal:  J Am Coll Cardiol       Date:  1991-10       Impact factor: 24.094

Review 10.  Sarcoid heart disease.

Authors:  Jaffer Syed; Robert Myers
Journal:  Can J Cardiol       Date:  2004-01       Impact factor: 5.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.